the rapid advancements in anti-aging medicine, emphasizing the potential of wearables, implantable devices, and biological age clocks to transform healthcare. Remote monitoring, telemedicine, and at-home diagnostic tests are becoming commonplace, reshaping how diseases like cancer and heart conditions are detected early. Epigenetic reprogramming and age-reversal treatments are also advancing quickly, with gene therapies showing promise in mice and soon humans. The hosts predict that these technologies will significantly extend healthy lifespans in the near future.
David A. Sinclair, A.O., Ph.D. is a tenured Professor in the Department of Genetics at the Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School, known for his research and controversial claims on aging and epigenetics.
https://sinclair.hms.harvard.edu/people/david-sinclair
0 Comments